Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$8,874,583
+$3,061,637 QoQ
Shares Held
7,399
+17.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#1,329
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 50%
Shared 50%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Belpointe Asset Management LLC holds $43,294,431 across 10 Drug Manufacturers - General names. LLY ranks #2 (20.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
46,672 | $11,744,542 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
7,399 | $8,874,583 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
125,071 | $7,206,591 | |
| 4 | JNJ |
Johnson & Johnson
|
16,266 | $4,131,076 | |
| 5 | MRK |
Merck & Co., Inc.
|
30,259 | $3,888,281 | |
| 6 | PFE |
Pfizer Inc
|
156,552 | $3,769,772 | |
| 7 | AMGN |
Amgen Inc
|
6,723 | $2,434,532 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,464 | $816,661 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,874,583 | 7,399 | Shares | Other | 2026-07-31 | |
| 2026-03-31 | $5,812,946 | 6,320 | Shares | Other | 2026-04-28 | |
| 2025-12-31 | $9,754,871 | 9,077 | Shares | Other | 2026-01-27 | |
| 2025-09-30 | $3,591,441 | 4,707 | Shares | Other | 2025-11-03 | |
| 2025-06-30 | $4,420,714 | 5,671 | Shares | Other | 2025-07-22 | |
| 2025-03-31 | $3,869,388 | 4,685 | Shares | Other | 2025-05-20 | |
| 2024-12-31 | $3,877,756 | 5,023 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $4,408,437 | 4,976 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $5,187,827 | 5,730 | Shares | Other | 2024-08-02 | |
| 2024-03-31 | $4,084,290 | 5,250 | Shares | Other | 2024-05-08 | |
| 2023-12-31 | $3,016,611 | 5,175 | Shares | Other | 2024-02-13 | |
| 2023-09-30 | $2,684,575 | 4,998 | Shares | Other | 2023-11-15 | |
| 2023-06-30 | $2,520,767 | 5,375 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $3,546,498 | 10,327 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,926,194 | 10,732 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $3,357,019 | 10,382 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,068,911 | 6,381 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $2,243,995 | 7,836 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $2,065,849 | 7,479 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,654,549 | 7,161 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,393,874 | 6,073 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,014,058 | 5,428 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $754,377 | 4,468 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $581,718 | 3,930 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $521,928 | 3,179 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $800,136 | 5,768 | Shares | Sole | 2020-07-20 | |
| No filing history on record for this holder in this stock. | ||||||